Incivo Finally Approved for Europeans with Hepatitis C
Share
Follow Us
J&J’s hep C drug Incivo approved in Europe
Published on 22/09/11
J&J’s potential blockbuster hepatitis C treatment Incivo has been approved in Europe.
Incivo (telaprevir) was approved in combination with peginterferon alfa and ribavirin, having demonstrated significant improvements in cure rates during three phase III studies.
“We are delighted by the European Commission approval of telaprevir and that we can now offer patients a significantly improved treatment option for hepatitis C virus (HCV) compared to the previous standard treatment,” said Ramon Polo, Telaprevir Compound Development team leader.
Incivo, known as Incivek in the US where it was approved in May, will now go head-to-head with another groundbreaking hep C medicine, Merck’s Victrelis.
Continue reading this entire article:
http://www.inpharm.com/news/167734/jj-hepatitis-c-drug-incivo-approved-europe
